BIOMARKER:

EGFR exon 2-7 deletion + EGFR amplification

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 2-7 deletion + EGFR amplification EGFR exon 2-7 deletion + EGFR amplification	Non Small Cell Lung Cancer NSCLC	EGFR exon 2-7 deletion + EGFR amplification EGFR exon 2-7 deletion + EGFR amplification	Non Small Cell Lung Cancer NSCLC	EGFR inhibitor Resistant: C3 – Early Trials	EGFR inhibitor Resistant: C3 – Early Trials
EGFR exon 2-7 deletion + EGFR amplification EGFR exon 2-7 deletion + EGFR amplification	Glioblastoma GBM	EGFR exon 2-7 deletion + EGFR amplification EGFR exon 2-7 deletion + EGFR amplification	Glioblastoma GBM	bevacizumab + osimertinib Sensitive: C3 – Early Trials	bevacizumab + osimertinib Sensitive: C3 – Early Trials